Study on related biomarkers of P53 gene

Study on related biomarkers of P53 gene

In theory, all p53 target genes are biomarkers of Gendicine, and one of the key research directions of the Scinosen team of scientists is the study of powerful P53 gene-related biomarkers, which is a bridge to the use of p53 gene therapy for various diseases. For example, it is used to treat various types of cancer, diabetes, heart disease, vascular diseases, etc., guiding us to realize unlimited possibilities. Our key research directions are as follows:

1. P53 gene functions as a transcription factor of ~3,660 genes

2. To explore the target genes in the process of apoptosis, neovascularization and metastasis of tumor cells and their destruction mechanisms

3. To study the role of p53 gene as tumor-associated antigen in immune activation